Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Advocates often highlight the opportunity for substantial therapeutic outcomes, particularly in ailments where conventional therapies have proven limited. However, crucially important to consider the significant financial burden associated with CP